Submit Feedback
Recent searches
    Trending searches
    Abbott Laboratories
    +
    Revenue breakdown by Products & Services
    Revenue breakdown by Geography

    Abbott Laboratories's Revenue by Segment

    In fiscal year , Abbott Laboratories's revenue by segment (products & services) are as follows:


    Learn more about Abbott Laboratories’s Revenue by Geography

    Check out competitors to Abbott Laboratories in a side-by-side comparison.

    Explore additional financial metrics for Abbott Laboratories.

    Continue reading...

    The above chart shows Abbott Laboratories's revenue percentage share by segment (products and services).

    In fiscal year 2022, Abbott Laboratories's revenue by segment is as follows:

    • Diagnostic Products generated $16.58B in revenue, representing 38% of its total revenue.
    • Established Pharmaceutical Products generated $4.91B in revenue, representing 11.26% of its total revenue.
    • Medical Devices generated $14.69B in revenue, representing 33.65% of its total revenue.
    • Nutritional Products generated $7.46B in revenue, representing 17.09% of its total revenue.

    The biggest segment for Abbott Laboratories is the Diagnostic Products, which represents 38% of its total revenue.
    The smallest segment for Abbott Laboratories is the Established Pharmaceutical Products, which represents 11.26% of its total revenue.

    The above chart shows Abbott Laboratories's revenue percentage share by segment (products and services).

    In fiscal year 2023, Abbott Laboratories's revenue by segment is as follows:

    • Diagnostic Products generated $9.99B in revenue, representing 24.91% of its total revenue.
    • Established Pharmaceutical Products generated $5.07B in revenue, representing 12.63% of its total revenue.
    • Medical Devices generated $16.89B in revenue, representing 42.12% of its total revenue.
    • Nutritional Products generated $8.15B in revenue, representing 20.34% of its total revenue.

    The biggest segment for Abbott Laboratories is the Medical Devices, which represents 42.12% of its total revenue.
    The smallest segment for Abbott Laboratories is the Established Pharmaceutical Products, which represents 12.63% of its total revenue.
    Continue reading...

    Summary Table

    Products & Services (Percent Share) 2022 2023 2024
    Diagnostic Products 38% 24.91% -
    Established Pharmaceutical Products 11.26% 12.63% -
    Medical Devices 33.65% 42.12% -
    Nutritional Products 17.09% 20.34% -
    Total Revenue 100% 100% 100%

    The above chart shows growth drivers and a year-over-year comparison of different segments' revenue.

  • Diagnostic Products revenue decreased -100% ($9.99B) from $9.99B (in 2023) to $0.00 (in 2024).
  • Established Pharmaceutical Products revenue decreased -100% ($5.07B) from $5.07B (in 2023) to $0.00 (in 2024).
  • Medical Devices revenue decreased -100% ($16.89B) from $16.89B (in 2023) to $0.00 (in 2024).
  • Nutritional Products revenue decreased -100% ($8.15B) from $8.15B (in 2023) to $0.00 (in 2024).
    • Continue reading...

    Summary Table

    Products & Services 2022
    Value Change
    		2023
    Value Change
    		2024
    Value Change
    Diagnostic Products $16.58B - $9.99B
    39.77%
    		- -
    Established Pharmaceutical Products $4.91B - $5.07B
    3.14%
    		- -
    Medical Devices $14.69B - $16.89B
    14.98%
    		- -
    Nutritional Products $7.46B - $8.15B
    9.32%
    		- -
    Total Revenue $43.64B - $40.10B
    8.13%
    		-
    100.00%

    Related company

    Related